Skip to main content
P&T COMMUNITY
Register
Sign in
Search

Search form

  • News
    • Approvals, Launches, & New Indications
    • Pipeline Plus
    • Research News
    • Industry Trends
    • Safety Issues
    • Agency Actions
    • Health Care Reform
    • Guidelines
    • Clinical Trials
  • P&T
    • Current issue
    • Past issues
    • Contact us
    • Digital Edition
    • Subscribe
  • P&T TV
    • Dr. David B. Nash
    • Meeting Reports
  • Health Care & Law
  • Drug Forecast
  • More
    • Meeting Highlights
    • Medication Errors
    • Prescription: Washington
    • Authors
    • About
    • Contact Us
  • News
  • P&T Journal
  • Formulary Kits
 
PTCommunity
Formulary Kits
  • INGREZZA®
    (valbenazine) tablets‎
  • JAKAFI®
    ruxolitinib (tablets)
  • PERSERIS™
    (risperidone) for extended-release injectable suspension
  • ZULRESSO™
    (brexanolone) injection CIV

You are here

  • Home
  • News by month %2 2018
  • News by month November 2018

PTCommunity News November 2018

  • FDA Approves Vitrakvi for TRK Fusion Cancers
  • New Treatment for Acute Myeloid Leukemia
  • RP-L102 Offers Hope for Children With Fanconi Anemia
  • FDA Will Update Its Medical Device Approval Process Following Trenchant Report
  • FDA Approves Gamifant for Primary Hemophagocytic Lymphohistiocytosis
  • New Indication for Promacta for Severe Aplastic Anemia
  • Don’t Use Sterile Drug Products From Pharm D Solutions, FDA Advises
  • FDA Advises Caution When Selecting Pain Medicine for Intrathecal Administration
  • Yupelri Approved for Chronic Obstructive Pulmonary Disease
  • Accipio Detects Brain Bleeds, Receives FDA 510(k) Clearance
  • Study Indicates Heart Improves with Diabetes Drug
  • New Drug Works With Other Drugs To Attack Pancreatic Cancer
  • Pfizer’s Lorbrena Approved for ALK Mutation Lung Cancer
  • FDA Approves Pegfilgrastim Biosimilar for Cancer
  • Mushroom Extract May Eradicate Human Papilloma Virus in Women
  • Fast-Acting Drug for Post-Partum Depression in the Works
  • Patient Enrollment Complete for Phase 3 Study of Alvimopan in Postoperative Ileus

STAY IN TOUCH!
SUBSCRIBE TO OUR NEWSLETTER

  • PTCommunity Newsletter

From the PharmD Corner

Up and Up They Go. Can Drug Prices Be Brought Down to Earth in 2019?
Dipal Patel, PharmD, RPh

P&T Resources

  • Formulary Kits
  • P&T Committee Resource Center
  • The PharmD Corner
  • Latest news
  • News archive
  • P&T TV
  • Industry announcements
  • Industry announcements archive
  • About P&T
  • Guidelines for authors
  • Editorial board
  • RSS feed

Useful Links

  • Contact us
  • 2019 Media Kit
  • 2019 Space and materials due dates
  • BPA statement
  • Subscribe
  • Renew your subscription
  • Update your subscription
  • Subscription customer service
  • Reprints
  • Terms and conditions for using this site
  • Contact webmaster

Clinical Brief

Multiple Sclerosis: New Perspectives on the Patient Journey–2019 Update
Summary of an Actuarial Analysis and Report

Click to download

P&T Product Profiler

ZULRESSO™ (brexanolone) injection CIV

Click to download

Contact Us

Editorial: Peter Wehrwein, Editor
Advertising:
Maureen Dwyer Liberti, Vice President, Group Publisher

Greg Pessagno, National Account Manager
Amy Birnbach, National Account Manager
Production: Dawn Flook, Director of Production Services
Webmaster: Webmaster

Terms and Conditions for Using this Site
© 2019 MediMedia, an ICON plc company.
All Rights Reserved.